A near-death experience
What was an uneventful full-term pregnancy and uncomplicated delivery turned critical just three hours postpartum when my healthy newborn baby girl suddenly turned blue in my arms. In a matter of seconds, she was rushed to the neonatal intensive care unit (NICU) to…
Source: healthydebate.ca – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
